RPAM
INMB icon

Rhenman & Partners Asset Management’s INmune Bio INMB Stock Holding History

Rhenman & Partners Asset Management’s Portfolio INMB Stock Details INMB Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q3 		– Sell
-178,284
Closed -$412K – 96
2025
Q2 		$412K Hold
178,284
– – 0.05% 90
2025
Q1 		$1.39M Hold
178,284
– – 0.16% 74
2024
Q4 		$833K Hold
178,284
– – 0.09% 88
2024
Q3 		$961K Hold
178,284
– – 0.08% 95
2024
Q2 		$1.57M Hold
178,284
– – 0.15% 80
2024
Q1 		$2.09M Hold
178,284
– – 0.2% 75
2023
Q4 		$2.01M Hold
178,284
– – 0.2% 74
2023
Q3 		$1.22M Hold
178,284
– – 0.13% 80
2023
Q2 		$1.62M Buy
+178,284
New +$1.43M 0.17% 77

Other funds holding INMB

BlackRock
BlackRock New York $5.7T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Raymond James Financial
Raymond James Financial St Petersburg, Florida $324B AUM 22.36% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return
Susquehanna International Group
Susquehanna International Group Bala Cynwyd, Pennsylvania $77.3B AUM 36.07% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $564B AUM 30.12% 1-Year Est. Return
WIM
Westside Investment Management Santa Monica, California $653M AUM 28.36% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return